Related CAS #
88851-62-1 (K); 79672-88-1 (free base)
Synonym
Piriprost potassium; U60,257B; U 60,257B; U-60,257B
IUPAC/Chemical Name
Cyclopenta(b)pyrrole-2-pentanoic acid, 1,4,5,6-tetrahydro-5-hydroxy-4-(3-hydroxy-1-octenyl)-1-phenyl-, monopotassium salt, (4R-(4alpha(1E,3S*),5beta))-
InChi Key
UFJDMFZMRXDIKI-FFGYHVHASA-M
InChi Code
InChI=1S/C26H35NO4.K/c1-2-3-5-13-21(28)15-16-22-23-17-20(12-8-9-14-26(30)31)27(24(23)18-25(22)29)19-10-6-4-7-11-19;/h4,6-7,10-11,15-17,21-22,25,28-29H,2-3,5,8-9,12-14,18H2,1H3,(H,30,31);/q;+1/p-1/b16-15+;/t21-,22+,25+;/m0./s1
SMILES Code
O=C([O-])CCCCC1=CC([C@@H](/C=C/[C@@H](O)CCCCC)[C@H](O)C2)=C2N1C3=CC=CC=C3.[K+]
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
463.66
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Esposito AL, Poirier WJ, Clark CA, Brown ML. The release of neutrophil chemoattractant activity by bronchoalveolar macrophages from adult and senescent mice. J Gerontol. 1989 Jul;44(4):B93-9. doi: 10.1093/geronj/44.4.b93. PMID: 2544639.
2: Antonipillai I, Nadler J, Horton R. Angiotensin feedback inhibition on renin is expressed via the lipoxygenase pathway. Endocrinology. 1988 Apr;122(4):1277-81. doi: 10.1210/endo-122-4-1277. PMID: 3126033.
3: Nadler JL, Natarajan R, Stern N. Specific action of the lipoxygenase pathway in mediating angiotensin II-induced aldosterone synthesis in isolated adrenal glomerulosa cells. J Clin Invest. 1987 Dec;80(6):1763-9. doi: 10.1172/JCI113269. PMID: 2824567; PMCID: PMC442451.
4: Smith RJ, Epps DE, Justen JM, Sam LM, Wynalda MA, Fitzpatrick FA, Yein FS. Human neutrophil activation with interleukin-1. A role for intracellular calcium and arachidonic acid lipoxygenation. Biochem Pharmacol. 1987 Nov 15;36(22):3851-8. doi: 10.1016/0006-2952(87)90449-7. PMID: 2825706.
5: Smith RJ, Sam LM, Justen JM, Leach KL, Epps DE. Human polymorphonuclear neutrophil activation with arachidonic acid. Br J Pharmacol. 1987 Jul;91(3):641-9. doi: 10.1111/j.1476-5381.1987.tb11258.x. PMID: 3111576; PMCID: PMC1853535.
6: Snider BG, Theis DL, Plaisted SM. Stability studies on piriprost and piriprost potassium using high-performance liquid chromatography. J Chromatogr. 1986 Sep 26;367(1):254-9. doi: 10.1016/s0021-9673(00)94842-8. PMID: 3536978.
7: Smith RJ, Yein FS, Speziale SC, Bowman BJ. A possible requirement for arachidonic acid lipoxygenation in the mechanism of phagocytic degranulation by human neutrophils stimulated with aggregated immunoglobulin G. Biochem Biophys Res Commun. 1986 Apr 14;136(1):310-5. doi: 10.1016/0006-291x(86)90911-3. PMID: 3010968.
8: Smith RJ, Bowman BJ, Speziale SC. Interleukin-1 stimulates granule exocytosis from human neutrophils. Int J Immunopharmacol. 1986;8(1):33-40. doi: 10.1016/0192-0561(86)90070-6. PMID: 2420732.
9: Hall ED. Beneficial effects of acute intravenous ibuprofen on neurologic recovery of head-injured mice: comparison of cyclooxygenase inhibition with inhibition of thromboxane A2 synthetase or 5-lipoxygenase. Cent Nerv Syst Trauma. 1985 Summer;2(2):75-83. doi: 10.1089/cns.1985.2.75. PMID: 3938345.
10: Morganroth ML, Reeves JT, Murphy RC, Voelkel NF. Leukotriene synthesis and receptor blockers block hypoxic pulmonary vasoconstriction. J Appl Physiol Respir Environ Exerc Physiol. 1984 May;56(5):1340-6. doi: 10.1152/jappl.1984.56.5.1340. PMID: 6373695.